4//SEC Filing
Darvish Nissim 4
Accession 0001178913-22-001072
CIK 0001534248other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:20 PM ET
Size
12.8 KB
Accession
0001178913-22-001072
Insider Transaction Report
Form 4
Darvish Nissim
Director
Transactions
- Purchase
American Depositary Shares
2022-03-11$4.28/sh+1,200$5,136→ 1,200 total - Award
Option to Purchase American Depositary Shares
2021-04-19+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying) - Award
Option to Purchase American Depositary Shares
2021-03-16+10,123→ 10,123 totalExercise: $0.80Exp: 2026-10-27→ American Depositary Shares (10,123 underlying) - Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying)
Footnotes (6)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]The ADSs are held of record directly by the Ashdanit Medical Ltd. (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole ultimate beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vest and become exercisable in their entirety on March 16, 2023, subject to the Reporting Person's continued service.
- [F5]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- [F6]The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001793602
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:20 PM ET
- Size
- 12.8 KB